Antara FDA Approval History
FDA Approved: Yes (First approved November 30, 2004)
Brand name: Antara
Generic name: fenofibrate
Dosage form: Capsules
Company: Reliant Pharmaceuticals, Inc.
Treatment for: Hypertriglyceridemia, High Cholesterol, Familial Heterozygous
Antara (fenofibrate) is a lipid-lowering agent approved as adjunctive therapy to diet for the treatment of elevated levels of cholesterol and triglycerides.
Development timeline for Antara
| Date | Article |
|---|---|
| Nov 30, 2004 | Approval Antara Reliant Pharmaceuticals, Inc. - Treatment for Hypercholesterolemia and Hypertriglyceridemia |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.